Passage:Hemoglobin
From MyMCAT
Hemoglobin is the iron-containing oxygen-transport metalloprotein in the red blood cells of vertebrates. In mammals, the protein makes up about 97% of the red blood cell’s dry content. Hemoglobin transports oxygen from the lungs or gills to the rest of the body, such as to the muscles, where it releases the oxygen for cell use.
Hemoglobin also has a variety of other roles in gas transport and effect-modulation which vary from species to species, and are quite diverse in some invertebrates. Hemoglobin can bind protons and carbon dioxide which causes a conformational change in the protein and facilitates the release of oxygen. Protons bind at various places along the protein, and carbon dioxide binds at the alpha-amino group forming carbamate.
When oxygen binds to the iron center, it causes contraction of the iron atom and movement back into the center of the porphyrin ring plane. This causes a tug on the peptide strand which tends to open up heme units in the remainder of the molecule, so that there is more room for oxygen molecules to bind at their heme sites. In the tetrameric form of normal adult hemoglobin, the binding of oxygen is thus a cooperative process. As a consequence, the oxygen binding curve of hemoglobin is sigmoidal, or S-shaped, as opposed to the normal hyperbolic curve associated with noncooperative binding. Hemoglobin binds with carbon monoxide 240 times more readily than with oxygen. The presence of carbon monoxide on one of the four heme sites causes the oxygen on the other heme sites to bind with greater affinity. This makes it difficult for hemoglobin to release oxygen to the tissues and has the effect of sequestering hemoglobin away from proper use. With an increased level of carbon monoxide, a person can suffer from severe hypoxemia while still maintaining a normal PO2.
In people acclimated to high altitudes, the concentration of 2,3-Bisphosphoglycerate (2,3-BPG) in the blood is increased, which allows these individuals to deliver a larger amount of oxygen to tissues under conditions of lower oxygen tension. This phenomenon, where molecule Y affects the binding of molecule X to a transport molecule Z, is called a heterotropic allosteric effect.
A decrease of hemoglobin, with or without an absolute decrease of red blood cells, leads to symptoms of anemia. Anemia has many different causes, although iron deficiency and its resultant iron deficiency anemia are the most common causes in the Western world. As absence of iron decreases heme synthesis, red blood cells in iron deficiency anemia are hypochromic (lacking the red hemoglobin pigment) and microcytic (smaller than normal). Other anemias are rarer. Some mutations in the globin chain are associated with the hemoglobinopathies, such as sickle-cell disease and thalassemia. Other benign mutations are referred to merely as hemoglobin variants. One group of genetic disorders, known as the porphyrias, are characterized not by mutations in the hemoglobin proteins but by errors in metabolic pathways of heme synthesis. King George III was probably the most famous sufferer of a porphyria condition, specifically, an autosomal dominant condition known as varietage prophyria.

